AI assistant
GlaxoSmithkline Pharmaceuticals Ltd. — Regulatory Filings 2023
Jun 27, 2023
60440_rns_2023-06-27_fb5fff03-65ae-443c-887c-db4bbc31b162.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [136 x 42] intentionally omitted <==
GlaxoSmithKline Pharmaceuticals Limited GSK House, Dr. Annie Besant Road, Worli, Mumbai - 400 030 Tel No: +91 22 2495 9595 Fax No: +91 22 2495 9494 Web: www.gsk-india.com Email: [email protected]
27[th] June 2023
To,
BSE LIMITED THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Dalal Street Bandra-Kurla Complex, Bandra (East) Mumbai - 400001 Mumbai - 400051
Dear Sirs,
Subject: Intimation of Schedule of Analyst / Institutional Investor Meetings under the Listing Regulations
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an analyst meeting is scheduled as per the details given below:
| Date of Meeting | Interaction with | Type | Place of meeting |
|---|---|---|---|
| 27thJune 2023 | SiMPL | Individual | Physical |
The information which is already in the public domain will be shared with Investor/Analyst.
Note: Dates are subject to Changes. Changes may happen due to exigencies on the part of Investors/Company.
This is for your information and record.
Yours faithfully
For GlaxoSmithKline Pharmaceuticals Limited
AJAY AVINASH Digitally signed by AJAY AVINASH NADKARNI NADKARNI Date: 2023.06.27 10:34:12 +05'30'
Ajay Nadkarni
Vice President – Administration, Real Estate & Company Secretary
CIN: L24239MH1924PLC001151